News
Humor from The New Yorker, including news satire by Andy Borowitz, funny cartoons and comics, Daily Shouts, and Shouts & Murmurs.
Shares in Eli Lilly rose sharply in pre-market trading today after the company reported the first phase 3 results for orforglipron, a GLP-1 agonist that it hopes will offer an oral alternative to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results